Mª DEL CARMEN
VIDAL PAN
Profesora titular de universidade
Charité
Berlín, AlemaniaPublicacións en colaboración con investigadores/as de Charité (7)
2024
-
Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data
World Allergy Organization Journal , Vol. 17, Núm. 7
2021
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial
Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10
-
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1041-1052
-
Placebo effects in allergen immunotherapy—An EAACI Task Force Position Paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 629-647
2018
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 827-836
2016
-
Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies
Clinical and Translational Allergy, Vol. 6, Núm. 1
2012
-
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
Clinical and Translational Allergy, Vol. 2, Núm. 1